Literature DB >> 7654823

Molecular genetics of human glioma.

B Westermark1, M Nistér.   

Abstract

This review focuses on genes that have a proven or presumed role in the genesis of astrocytic tumors. A common theme in glioblastoma is the amplification of genes that code for growth factor receptors of the protein-tyrosine kinase family (epidermal growth factor receptor, platelet-derived growth factor receptor-alpha, met). The majority of glioblastomas also have alterations in genes that encode factors that are involved in cyclin-dependent kinase activity, which is a critical step in G1-S transition in the cell cycle. These alterations include deletions of negative regulatory elements (TP53, CDKN2, MTS2) and amplification of positive factors (MDM2, CDK4). In addition, there are loci on chromosomes 10 and 19q that seem to be involved in tumor progression.

Entities:  

Mesh:

Year:  1995        PMID: 7654823     DOI: 10.1097/00001622-199505000-00005

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  9 in total

Review 1.  Growth factors in gliomas: antisense and dominant negative mutant strategies.

Authors:  J W Campbell; I F Pollack
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

2.  Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain.

Authors:  F B Furnari; H Lin; H S Huang; W K Cavenee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

Review 3.  The role of transforming growth factor beta in glioma progression.

Authors:  M T Jennings; J A Pietenpol
Journal:  J Neurooncol       Date:  1998-01       Impact factor: 4.130

4.  Conversion of a radioresistant phenotype to a more sensitive one by disabling erbB receptor signaling in human cancer cells.

Authors:  D M O'Rourke; G D Kao; N Singh; B W Park; R J Muschel; C J Wu; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

5.  Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt pathway.

Authors:  Venkata Ramesh Dasari; Kiranpreet Kaur; Kiran Kumar Velpula; Meena Gujrati; Daniel Fassett; Jeffrey D Klopfenstein; Dzung H Dinh; Jasti S Rao
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

6.  Strong inhibition of replicative DNA synthesis in the developing rat cerebral cortex and glioma cells by roscovitine.

Authors:  Juan Sebastian Yakisich; Marina Fernanda Vita; Ake Siden; Deborah Ruth Tasat; Mabel Cruz
Journal:  Invest New Drugs       Date:  2009-04-24       Impact factor: 3.850

7.  In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms.

Authors:  J W Mandell; I M Hussaini; M Zecevic; M J Weber; S R VandenBerg
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

8.  Combination gene therapy with PTEN and EGFR siRNA suppresses U251 malignant glioma cell growth in vitro and in vivo.

Authors:  Lei Han; An-ling Zhang; Peng Xu; Xiao Yue; Yang Yang; Guang-xiu Wang; Zhi-fan Jia; Pei-yu Pu; Chun-sheng Kang
Journal:  Med Oncol       Date:  2009-08-29       Impact factor: 3.064

9.  Snail depletes the tumorigenic potential of glioblastoma.

Authors:  K Savary; D Caglayan; L Caja; K Tzavlaki; S Bin Nayeem; T Bergström; Y Jiang; L Uhrbom; K Forsberg-Nilsson; B Westermark; C-H Heldin; M Ferletta; A Moustakas
Journal:  Oncogene       Date:  2013-03-25       Impact factor: 9.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.